Status:
TERMINATED
European Study of POBA Versus Cotavance(R) Paclitaxel Coated Balloon for the Treatment of Infrapopliteal Lesions in Critical Limb Ischemia (EURO CANAL)
Lead Sponsor:
Bayer
Conditions:
PAD
Infrapopliteal Lesions
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
To evaluate the procedural safety and to identify and characterize therapeutic and functional endpoint assessments in subjects with documented critical limb ischemia who received treatment with the Co...
Eligibility Criteria
Inclusion
- \- Subjects with CLI
Exclusion
- Participation in another research trial
- Medical conditions the study doctor will assess
Key Trial Info
Start Date :
August 15 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 15 2013
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT01260870
Start Date
August 15 2011
End Date
July 15 2013
Last Update
January 30 2024
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University
Graz, Austria
2
AZ St.-Blasius Hospital
Dendermonde, Belgium
3
University Hospital
Ghent, Belgium
4
University Hospital
Bern, Switzerland